Zepbound 5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FM0DQ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $7,651
Award facts
- Contract value 100% obligated
- $7,651.06 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,651.06 to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Zepbound (semaglutide) 5 mg/0.5 mL pens. This firm fixed-price delivery order, which is expected to be completed by December 9, 2025, represents a non-competitive award issued under an existing contract vehicle. The product will be delivered to the company's facility in Conshohocken, Pennsylvania. Zepbound is a GLP-1 receptor agonist indicated for weight management and is part of the expanding pharmaceutical portfolio that the Defense Health Agency and military healthcare systems have been procuring to support patient care across the federal medical supply chain.
This delivery order derives from AmerisourceBergen Drug Corp's significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor serving federal healthcare systems, AmerisourceBergen Drug Corp has demonstrated consistent capability in fulfilling competitive federal procurement requirements across a broad spectrum of medications and medical supplies. The parent IDC enables the company to supply pharmaceutical products to military healthcare programs globally, including support to the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities, positioning this Zepbound delivery order within a comprehensive and strategic pharmaceutical supply relationship supporting military and veteran healthcare needs.
Quick answers
Who was awarded contract SPE2DR26FM0DQ?
SPE2DR26FM0DQ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 8, 2025.
How much is contract SPE2DR26FM0DQ worth?
The government has obligated $7,651 on SPE2DR26FM0DQ.
Is contract SPE2DR26FM0DQ an order under another contract?
Yes. SPE2DR26FM0DQ is a delivery order under SPE2DR25D3501, an indefinite delivery contract.
Was contract SPE2DR26FM0DQ competed?
The extent of competition for SPE2DR26FM0DQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award